n-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)formamide, 95+%, 250mg

1,4,6,7-Tetrahydropyrano[4,3-c]pyrazole, 100mg

4,5-Dicyanoimidazole, 97.0%, 25g

3',5'-Dimethoxyacetophenone, 95.0%, 5g

Caja criogénica ROTILABO® sin división, negro, Altura, 75 mm, 5 Pieza(s)

2-Methylene-1,3-dioxepane, 95.0%, 5g

N,N'-dimetilpropilenurea, SOLVAGREEN®, mínimo 99 %, para síntesis, 500 ml

2-[4-(PIPERIDIN-3-YL)PHENYL]-2H-INDAZOLE-7-CARBOXAMIDE, 95%, 250mg

4-Bromo-2,5-dichloro-6-fluorobenzaldehyde, 1g

7-Bromobenzo[d]thiazol-2-amine, 95.0%, 100mg

(S)-1-(4-Chlorophenyl)ethanol, 95.0%, 10g

3,6-Diphenyl-1,2,4,5-tetrazine>98.0%(qNMR)1g

N,N-Diphenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline>98.0%(HPLC)(T)1g